Article Information
vol. 5 no. 203 203ra125
- Received for publication March 4, 2013
- Accepted for publication July 12, 2013
- .
Author Information
- Mark Cobbold1,2,*,†,
- Hugo De La Peña2,*,
- Andrew Norris3,
- Joy M. Polefrone3,
- Jie Qian3,
- Ann Michelle English3,
- Kara L. Cummings1,
- Sarah Penny2,
- James E. Turner2,
- Jennifer Cottine3,
- Jennifer G. Abelin3,
- Stacy A. Malaker3,
- Angela L. Zarling1,
- Hsing-Wen Huang2,
- Oliver Goodyear2,
- Sylvie D. Freeman2,
- Jeffrey Shabanowitz3,
- Guy Pratt4,
- Charles Craddock5,6,
- Michael E. Williams7,
- Donald F. Hunt3,8 and
- Victor H. Engelhard1,†
- 1Carter Immunology Center and Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
- 2Medical Research Council Centre for Immune Regulation and Clinical Immunology Service, School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
- 3Department of Chemistry, University of Virginia, Charlottesville, VA 22901, USA.
- 4Cancer Research UK Institute for Cancer Studies, School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK.
- 5Cancer Research UK Clinical Trials Unit, School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK.
- 6Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham B15 2TH, UK.
- 7Division of Hematology/Oncology and Hematologic Malignancy Program, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
- 8Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA.
- ↵†Corresponding author. E-mail: m.cobbold{at}bham.ac.uk (M.C.); vhe{at}virginia.edu (V.H.E.)